Molecular Partners AG
MOLN4.700USD
+0.090+1.95%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
175.78M시가총액
손실P/E TTM
자세한 내용은 Molecular Partners AG 회사
Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.
Molecular Partners AG 정보
종목 코드 MOLN
회사 이름Molecular Partners AG
상장일Oct 22, 2014
CEOAmstutz (Patrick)
직원 수159
유형Depository Receipt
회계 연도 종료Oct 22
주소Wagistrasse 14
도시SCHLIEREN
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Switzerland
우편 번호8952
전화41447557700
웹사이트https://www.molecularpartners.com/
종목 코드 MOLN
상장일Oct 22, 2014
CEOAmstutz (Patrick)
Molecular Partners AG의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Michael Tobias Stumpp, Ph.D.
Dr. Michael Tobias Stumpp, Ph.D.
Executive Vice President - Projects, Member of the Management Board
Executive Vice President - Projects, Member of the Management Board
--
--
Dr. Patrick Amstutz, Ph.D.
Dr. Patrick Amstutz, Ph.D.
Chief Executive Officer, Executive Director, Member of the Management Board
Chief Executive Officer, Executive Director, Member of the Management Board
--
--
Mr. Steven H. (Steve) Holtzman, Ph.D.
Mr. Steven H. (Steve) Holtzman, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. William M. (Bill) Burns
Mr. William M. (Bill) Burns
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Seth D. Lewis
Mr. Seth D. Lewis
Senior Vice President - Investor Relations and Strategy
Senior Vice President - Investor Relations and Strategy
--
--
Mr. Sandip S. Kapadia, CPA
Mr. Sandip S. Kapadia, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Vito J. Palombella, Ph.D.
Dr. Vito J. Palombella, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Michael Vasconcelles, M.D.
Dr. Michael Vasconcelles, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Agnete B. Fredriksen, Ph.D.
Dr. Agnete B. Fredriksen, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Dominik Hoechli, M.D.
Dr. Dominik Hoechli, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Michael Tobias Stumpp, Ph.D.
Dr. Michael Tobias Stumpp, Ph.D.
Executive Vice President - Projects, Member of the Management Board
Executive Vice President - Projects, Member of the Management Board
--
--
Dr. Patrick Amstutz, Ph.D.
Dr. Patrick Amstutz, Ph.D.
Chief Executive Officer, Executive Director, Member of the Management Board
Chief Executive Officer, Executive Director, Member of the Management Board
--
--
Mr. Steven H. (Steve) Holtzman, Ph.D.
Mr. Steven H. (Steve) Holtzman, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. William M. (Bill) Burns
Mr. William M. (Bill) Burns
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Seth D. Lewis
Mr. Seth D. Lewis
Senior Vice President - Investor Relations and Strategy
Senior Vice President - Investor Relations and Strategy
--
--
Mr. Sandip S. Kapadia, CPA
Mr. Sandip S. Kapadia, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
수익 분석
통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2025Q3
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
기업이 아직 관련 데이터를 공개하지 않았습니다.
지역별USD
이름
수익
비율
Switzerland
0.00
0.00%
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Sun, Aug 17
마지막 업데이트: Sun, Aug 17
주주
주주 유형
주주
주주
비율
Suvretta Capital Management, LLC
5.94%
BVF Partners L.P.
3.62%
기타
90.44%
주주
주주
비율
Suvretta Capital Management, LLC
5.94%
BVF Partners L.P.
3.62%
기타
90.44%
주주 유형
주주
비율
Hedge Fund
9.56%
기타
90.44%
기관 주식 보유
마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
15
3.58M
9.57%
-32.28K
2025Q3
15
3.59M
9.59%
-23.51K
2025Q2
16
3.58M
9.72%
-44.38K
2025Q1
16
3.58M
9.72%
-44.38K
2024Q4
16
3.58M
10.80%
+1.75M
2024Q3
19
850.31K
2.56%
-138.97K
2024Q2
20
861.27K
2.60%
-213.87K
2024Q1
22
946.77K
2.88%
-611.83K
2023Q4
26
957.56K
2.63%
-624.65K
2023Q3
28
961.52K
2.93%
-686.56K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Suvretta Capital Management, LLC
2.22M
5.94%
--
--
Sep 30, 2025
BVF Partners L.P.
1.35M
3.62%
--
--
Sep 30, 2025
Geode Capital Management, L.L.C.
1.07K
0%
--
--
Nov 30, 2025
Morgan Stanley & Co. LLC
367.00
0%
--
--
Sep 30, 2025
UBS Financial Services, Inc.
5.34K
0.01%
-4.86K
-47.65%
Sep 30, 2025
BofA Global Research (US)
157.00
0%
--
--
Sep 30, 2025
EverSource Wealth Advisors, LLC
155.00
0%
+114.00
+278.05%
Sep 30, 2025
Rhumbline Advisers Ltd. Partnership
--
0%
-269.00
-100.00%
Jun 30, 2025
Qube Research & Technologies Ltd
--
0%
-16.00
-100.00%
Sep 30, 2024
Old Mission Capital LLC
--
0%
-10.37K
-100.00%
Sep 30, 2024
더 보기
관련 ETF
이름
비율
데이터 없음
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
